Stereotaxis

STXS

----

Current ValuationThe current P/E ratio is -4.72, above the reasonable range, cheaper than 0.08% of the time in the past 5 years, and the industry ranks 113/173, the industry Median -0.92.

-4.72xP/E

Stock price$1.11Earnings per share$-0.24

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

012243648

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
BAXUSBaxter	-11.84x	141.71%	$12.59B
GKOSUSGlaukos	-51.97x	75.37%	$9.77B
TFXUSTeleflex	-5.14x	118.39%	$5.30B
PLSEUSPulse Biosciences	-47.94x	27.55%	$3.84B
IRTCUSIRhythm	-252.18x	70.88%	$3.52B
BFLYUSButterfly Network	-29.35x	34.41%	$2.20B
AXGNUSAxogen	-63.19x	18.38%	$2.12B
ASSTUSStrive	-1.97x	63.23%	$1.92B
NVCRUSNovocure	-11.43x	1.23%	$1.70B
ATECUSAlphatec	-14.98x	41.67%	$1.65B
KMTSUSKestra Medical Tech	-10.55x	0.94%	$1.58B
DRTSUSAlpha Tau Medical	-14.37x	--	$1.33B
TNDMUSTandem Diabetes	-17.70x	77.60%	$1.12B
PRCTUSPROCEPT BioRobotics	-9.60x	3.47%	$1.05B
IARTUSIntegra LifeSciences	-144.43x	109.42%	$1.05B
AORTUSArtivion	-324.84x	266.67%	$1.04B
ENOVUSEnovis	-0.93x	100.97%	$1.02B
BBNXUSBeta Bionics	-12.72x	11.66%	$928.08M
QDELUSQuidelOrtho	-0.88x	75.33%	$920.28M
CBLLUSCeribell	-13.74x	35.15%	$906.87M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.